Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03312569 · ClinicalTrials.gov registry record

Robotic-assisted and Laparoscopic Right Colectomy Study - Intracorporeal vs. Extracorporeal Anastomoses

A clinical trial, sponsored by Intuitive Surgical.

Completed
Registry status
306
Enrollment target

NCT03312569: Completed study, sponsored by Intuitive Surgical.

NCT03312569 is a clinical trial that has completed, run by Intuitive Surgical. The registered enrollment target is 306 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03312569 has completed, sponsored by Intuitive Surgical.

COMPLETED
Registry status
306 participants
Enrollment target

Study Summary

To compare intracorporeal and extracorporeal anastomoses for robotic-assisted and laparoscopic right colectomies

Primary Outcome

The primary endpoint of the study is the incidence of incisional hernia for intracorporeal and extracorporeal anastomoses within one year after the right colectomy procedure. Incidence of incisional hernia either patient self-reported or clinical diagnosis will be assessed at one year after the right colectomy procedure.

Interventions

  • PROCEDURE Right Colectomy with Intracorporeal Anastomosis
  • PROCEDURE Right Colectomy with Extracorporeal Anastomosis

Trial Details

FieldValue
Enrollment Target 306 participants
Start Date 2018-02-01
Est. Completion 2023-07-24
Intuitive Surgical

40 total trials

What the finished NCT03312569 record still lists

NCT03312569 is an observational study that tracks outcomes without assigning an intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Right Colectomy with Intracorporeal Anastomosis is the first listed.

NCT03312569 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03312569 about?

NCT03312569 is a clinical study titled "Robotic-assisted and Laparoscopic Right Colectomy Study - Intracorporeal vs. Extracorporeal Anastomoses". To compare intracorporeal and extracorporeal anastomoses for robotic-assisted and laparoscopic right colectomies

What is the current status of trial NCT03312569?

This trial is currently completed. The enrollment target is 306 participants. The study started on 2018-02-01. Estimated completion is 2023-07-24.

What interventions are being tested in trial NCT03312569?

The interventions under investigation include: Right Colectomy with Intracorporeal Anastomosis (PROCEDURE), Right Colectomy with Extracorporeal Anastomosis (PROCEDURE).

Who is sponsoring clinical trial NCT03312569?

This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05078970 · 306 participants · NA

    Advancing Suicide Intervention Strategies for Teens During High Risk Periods

  • NCT05843695 · 306 participants · NA

    Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety

  • NCT06057337 · 306 participants · NA

    Families With Pride ("Familias Con Orgullo").

  • NCT06498635 · 306 participants · Phase 3

    Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03312569, the US trial registry maintained by the National Library of Medicine. NCT03312569 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.